Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9052 |
High Similarity |
NPD5283 |
Phase 1 |
0.8644 |
High Similarity |
NPD5535 |
Approved |
0.8293 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.8258 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.8168 |
Intermediate Similarity |
NPD7095 |
Approved |
0.816 |
Intermediate Similarity |
NPD5585 |
Approved |
0.8116 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.8116 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.8 |
Intermediate Similarity |
NPD2653 |
Approved |
0.7969 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7953 |
Intermediate Similarity |
NPD17 |
Approved |
0.7926 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7917 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7874 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7852 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7851 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7846 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7846 |
Intermediate Similarity |
NPD4359 |
Approved |
0.784 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7836 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7836 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7836 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7833 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7829 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7829 |
Intermediate Similarity |
NPD1281 |
Approved |
0.782 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7805 |
Intermediate Similarity |
NPD228 |
Approved |
0.7778 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7769 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7754 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7754 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7721 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7708 |
Intermediate Similarity |
NPD3647 |
Clinical (unspecified phase) |
0.7704 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7698 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7674 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7652 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7642 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7642 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7634 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.763 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7615 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7615 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7597 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7594 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7594 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7594 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7586 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7576 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7576 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7569 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7554 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7554 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7519 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7518 |
Intermediate Similarity |
NPD4870 |
Approved |
0.7518 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7518 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7518 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7518 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7483 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7481 |
Intermediate Similarity |
NPD2237 |
Approved |
0.7481 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7463 |
Intermediate Similarity |
NPD987 |
Approved |
0.7459 |
Intermediate Similarity |
NPD9697 |
Approved |
0.7447 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7447 |
Intermediate Similarity |
NPD2531 |
Phase 2 |
0.7445 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7444 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7426 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7426 |
Intermediate Similarity |
NPD2614 |
Approved |
0.741 |
Intermediate Similarity |
NPD1933 |
Approved |
0.741 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7405 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7405 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7391 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7388 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7376 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7364 |
Intermediate Similarity |
NPD3596 |
Phase 2 |
0.7361 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7357 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7357 |
Intermediate Similarity |
NPD4579 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7347 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7343 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.7343 |
Intermediate Similarity |
NPD5958 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7338 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD6873 |
Phase 2 |
0.7328 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7324 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7319 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7319 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD7644 |
Approved |
0.7299 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7299 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7297 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7293 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7292 |
Intermediate Similarity |
NPD4162 |
Approved |
0.729 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7287 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7286 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7286 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7279 |
Intermediate Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7279 |
Intermediate Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD3146 |
Approved |
0.7273 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7273 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7266 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7252 |
Intermediate Similarity |
NPD6581 |
Approved |
0.7252 |
Intermediate Similarity |
NPD6580 |
Approved |
0.7248 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7248 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7248 |
Intermediate Similarity |
NPD4210 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD5163 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7237 |
Intermediate Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7222 |
Intermediate Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.7214 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7203 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7203 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7197 |
Intermediate Similarity |
NPD3445 |
Approved |
0.7197 |
Intermediate Similarity |
NPD6830 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD3444 |
Approved |
0.7197 |
Intermediate Similarity |
NPD3443 |
Approved |
0.7194 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7194 |
Intermediate Similarity |
NPD3374 |
Clinical (unspecified phase) |
0.7194 |
Intermediate Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD3020 |
Approved |
0.719 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7172 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD37 |
Approved |
0.7164 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7164 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7163 |
Intermediate Similarity |
NPD4622 |
Approved |
0.7163 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7163 |
Intermediate Similarity |
NPD4618 |
Approved |
0.7163 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7154 |
Intermediate Similarity |
NPD6387 |
Discontinued |
0.7154 |
Intermediate Similarity |
NPD2557 |
Approved |
0.7153 |
Intermediate Similarity |
NPD5865 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6875 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4481 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD6876 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2423 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD2107 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7132 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7132 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7121 |
Intermediate Similarity |
NPD1182 |
Approved |
0.712 |
Intermediate Similarity |
NPD968 |
Approved |
0.7114 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7111 |
Intermediate Similarity |
NPD1840 |
Phase 2 |
0.7111 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7105 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7105 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7103 |
Intermediate Similarity |
NPD2808 |
Discontinued |
0.7103 |
Intermediate Similarity |
NPD2897 |
Discontinued |
0.7092 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7092 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7075 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7071 |
Intermediate Similarity |
NPD7985 |
Registered |
0.7067 |
Intermediate Similarity |
NPD6031 |
Approved |
0.7067 |
Intermediate Similarity |
NPD6030 |
Approved |
0.7063 |
Intermediate Similarity |
NPD5689 |
Approved |
0.7063 |
Intermediate Similarity |
NPD290 |
Approved |
0.7063 |
Intermediate Similarity |
NPD5688 |
Approved |
0.7059 |
Intermediate Similarity |
NPD1669 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD3685 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7054 |
Intermediate Similarity |
NPD821 |
Approved |
0.7051 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7034 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7034 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7034 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7029
|
Intermediate Similarity |
NPD4624 |
Approved |